Quantumzyme is a deep tech biotechnology company providing green solutions to chemical and pharmaceutical companies
What We Do
Quantumzyme Corp. is a leading innovator in biotransformation, specializing in enzyme engineering to develop sustainable, efficient, and eco-friendly alternatives to traditional chemical processes. By leveraging advanced technologies such as quantum mechanics, molecular modeling, and computational enzyme design, Quantumzyme enhances enzyme activity, selectivity, and stability.
Value Proposition
One and only
Quantumzyme Corp. is the first company in the world to offer enzyme engineering based on advanced computational approaches like QM.
Designer Enzymes
Quantumzyme Corp. is able to custom design enzymes based on varied needs and provide optimal solutions for commercial success.
IP Free Enzyme
Enzymes designed and engineered are usually novel IP and allow freedom to operate as well as asset creation.
Scientifically Advanced
All our solutions are based on the QZyme Workbench(TM) framework and reveal previously unknown information about catalysis leading to better product strategy.
Why Us
Quantumzyme is revolutionizing biotransformation with QZyme Workbench(TM), providing sustainable enzyme solutions for pharmaceuticals, fragrances, food, and textiles. Moving beyond traditional enzyme evolution, Quantumzyme designs precision biocatalysts while enabling digital product life cycle management. Committed to sustainability, it helps industries reduce hazardous substances with cutting-edge, eco-friendly alternatives. With expertise in discovery, engineering, and scale-up, Quantumzyme sets a new standard in enzyme-driven manufacturing.
Want to reduce or eliminate the use of hazardous substances? Thinking of shelving your sustainability initiatives? Take the next step and talk to us.
Market Potential
Potential revenue of $2B over the next 7 years
Flavors & Fragrance
Valued at $39.3Bn by 2028
Opportunity: ~ $0.25B next 5 years
Food & Beverages
Valued at $8.1Bn by 2028
Opportunity: ~ $0.5B next 5 years
Pharmaceutical
Valued at $80Bn by 2028
Opportunity: ~ $1B next 5 years
Fine Chemical & Dyes
Valued at $1.7Bn by 2028
Opportunity: ~ $0.5B next 5 years
Plastics, Polymerisation, De-polymerization
Valued at $6.3Bn by 2028
Opportunity: ~ $0.25B next 5 years
The crew
Naveen Krishnarao Kulkarni
Mr. Kulkarni has two and a half decades of healthcare & biotech experience covering a broad range of scientific, entrepreneurial and innovation strategies in markets spanning Europe, the USA, Australia, and India. From 2017 through February 2023, when the Company acquired various assets from Mr. Kulkarni, Mr. Kulkarni was working on and formulating the concept and business model of what would become the current iteration of the Company. To this end, he was instrumental in raising seed capital, implementing the initial business plan and plan of operations, and positioning the company to operate as an IP driven business. From 2011 to 2016, Mr. Kulkarni was a Director and CEO of Cryo Stemcell Pvt. Ltd. where he was instrumental in the turnaround of the company from a stem cell banking service provider to a healthcare company. He also developed a business plan for next level funding and initiated PRP therapy and hospital partnerships with new customer acquisition and sales team mobilization plan for India. From November 2007 to October 2011, Mr. Kulkarni was a director at Philips Research, Asia, where he was involved in identifying and developing ventures for spin-ups, spin-ins and spin-outs in Philips with a portfolio of opportunities for new business creation across healthcare and energy relevant for India, emerging markets and globally.
Dr. Manu Bharath
Dr. Bharath is an experienced Otorhinolaryngologist, who has worked for the last 14 years as an ENT performing head & neck surgeries. Since 2017, Dr. Bharath has been practicing at Pristyn Care Clinics in Bangalore, Pristyn Care is a health care startup that focuses outpatient procedures. He graduated and obtained his MBBS degree from JSS Medical College, Sri Shivarathreeshwara Nagar, Mysore in 2009, and then obtained his postgraduate MS degree from Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Adgaon, Nashik in 2017. Since 2017, Dr. Bharath has been practicing at Pristyn Care Clinics in Bangalore. Pristyn Care is a health care startup that focuses on day care procedures.
Dr. Shrutin Ashok Ulman
Dr. Ulman is a qualified senior professional with 30 years’ experience in life sciences/medical devices including end-to-end product development and management, value proposition development in diagnostics and therapeutics. Seeking challenging senior managerial assignments with a reputed organization to utilize acquired skills in accomplishing organizational growth objectives. Specifically, since 2019, Dr. Ulman has been acting as a director Philips, India where his work includes defining and setting up strategic partnerships and interacting with the stakeholders to align product deliverables to the business requirements of the clients, spearheading and collaborating with multiple teams for piloting clinical trials and clinical studies, focusing on R&D innovation, and rolling out new product development strategies, and working on digital therapeutics. Additionally, he is currently the Head Researcher of Africa Philips, Nairobi, working to ensure access to care, sustainability, and risk management of value/supply chains catering to areas like Digital Primary Care Solutions and Digital Therapeutics.